JPMorgan Chase & Co’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $774 | Sell |
469
-78
| -14% | -$129 | ﹤0.01% | 5761 |
|
|
2025
Q1 | $728 | Buy |
547
+2
| +0.4% | +$3 | ﹤0.01% | 5786 |
|
|
2024
Q4 | $1.02K | Sell |
545
-3
| -0.5% | -$6 | ﹤0.01% | 5676 |
|
|
2024
Q3 | $425 | Buy |
548
+79
| +17% | +$61 | ﹤0.01% | 5748 |
|
|
2024
Q2 | $352 | Hold |
469
| – | – | ﹤0.01% | 5698 |
|
|
2024
Q1 | $497 | Hold |
469
| – | – | ﹤0.01% | 5705 |
|
|
2023
Q4 | $492 | Hold |
469
| – | – | ﹤0.01% | 5888 |
|
|
2023
Q3 | $525 | Hold |
469
| – | – | ﹤0.01% | 5760 |
|
|
2023
Q2 | $706 | Hold |
469
| – | – | ﹤0.01% | 5599 |
|
|
2023
Q1 | $1K | Hold |
469
| – | – | ﹤0.01% | 5670 |
|
|
2022
Q4 | $0 | Sell |
469
-232,399
| -100% | – | ﹤0.01% | 5860 |
|
|
2022
Q3 | $310K | Sell |
232,868
-334,179
| -59% | -$445K | ﹤0.01% | 3982 |
|
|
2022
Q2 | $1.26M | Sell |
567,047
-23,374
| -4% | -$51.9K | ﹤0.01% | 3316 |
|
|
2022
Q1 | $3.65M | Buy |
590,421
+580,317
| +5,743% | +$3.59M | ﹤0.01% | 2772 |
|
|
2021
Q4 | $128K | Sell |
10,104
-3,405
| -25% | -$43.1K | ﹤0.01% | 4732 |
|
|
2021
Q3 | $1.24M | Buy |
13,509
+1,345
| +11% | +$123K | ﹤0.01% | 3473 |
|
|
2021
Q2 | $645K | Buy |
12,164
+3,277
| +37% | +$174K | ﹤0.01% | 3857 |
|
|
2021
Q1 | $321K | Sell |
8,887
-8,315
| -48% | -$300K | ﹤0.01% | 4267 |
|
|
2020
Q4 | $477K | Buy |
17,202
+6,483
| +60% | +$180K | ﹤0.01% | 3773 |
|
|
2020
Q3 | $539K | Buy |
10,719
+336
| +3% | +$16.9K | ﹤0.01% | 3355 |
|
|
2020
Q2 | $481K | Sell |
10,383
-3,952
| -28% | -$183K | ﹤0.01% | 3316 |
|
|
2020
Q1 | $654K | Buy |
14,335
+2,334
| +19% | +$106K | ﹤0.01% | 3181 |
|
|
2019
Q4 | $673K | Buy |
12,001
+8,715
| +265% | +$489K | ﹤0.01% | 3282 |
|
|
2019
Q3 | $82K | Buy |
3,286
+1,341
| +69% | +$33.5K | ﹤0.01% | 4061 |
|
|
2019
Q2 | $78K | Buy |
+1,945
| New | +$78K | ﹤0.01% | 4100 |
|